30/05/2025
From May 2nd to 6th, 2025, Associate Professor Janjira Petsuksiri, MD, from the Division of Radiation Oncology at Siriraj Hospital, Mahidol University, presented her research on treatment approaches for stage III endometrial cancer at the ESTRO 2025 Congress in Vienna, Austria. Her study, comparing adjuvant chemotherapy to combined chemotherapy and radiation therapy, was shared as a digital poster and is intended for international publication.
The congress, themed “Transformative Innovation Through Partnership,” focused on advancing radiation oncology through collaboration and innovation, aligning with ESTRO’s 2030 vision of achieving optimal health for all through equitable cancer care.
"Siriraj Faculty Abroad at ESTRO 2025 in Austria"
From May 2nd – 6th, 2025, Associate Professor Janjira Petsuksiri, MD, a lecturer from the Division of Radiation Oncology, Department of Radiology, Faculty of Medicine Siriraj Hospital, Mahidol University, presented a digital poster titled, "Adjuvant chemotherapy versus combined chemotherapy and radiation therapy in stage III endometrial cancer: A propensity score matching study" at "The European SocieTy for Radiotherapy and Oncology (ESTRO) 2025 Congress" in Vienna, the Republic of Austria. Assoc. Prof. Petsuksiri aims to publish this research in an international publication.
ESTRO 2025 Congress, themed "Transformative Innovation Through Partnership," aims to strengthen radiation oncology's role in multidisciplinary cancer care and ensure equitable access to high-value radiation therapy for all cancer patients. The society's vision statement for 2030, "Radiation Oncology. Optimal Health for All, Together," underscores this commitment.
The congress focused on pioneering research and collaboration to advance the boundaries of radiation oncology and multidisciplinary cancer care. State-of-the-art sessions featured panel discussions, pitch sessions, and debates, fostering mutual learning and cooperation among stakeholders.